维甲酸对人神经母细胞瘤SK—N—SH细胞形态结构和分化标志物表达的影响

目的：观察维甲酸对人神经母细胞瘤SK-N-SH细胞形态与超微结构及其相关标志物表达的影响,以鉴定其对神经母细胞瘤细胞终末分化的诱导作用。方法：1μmol／L维甲酸处理SK—N—SH细胞,光镜、电镜和免疫细胞化学检测研究SK—N—SH细胞处理前后细胞形态、超微结构变化和神经元相关标志物的表达变化。结果：光镜与电镜观察结果显示,SK—N—SH细胞经1μmol／LRA处理后,细胞形态和超微结构产生了细胞呈极性状、伸出多个轴突树突状突起、细胞逐渐变小变圆并融合在一起形成类似神经节样结构、细胞表面微绒毛减少、核仁变少变小、常染色质增多、细胞器丰富发达等显著变化;免疫细胞化学检测显示经RA处理后SK-N-SH细胞NSE、MAP2、Synaptophysin的表达较对照组细胞明显加强。结论：维甲酸能改变SK—N—SH细胞形态和超微结构恶性表型特征,并促进与神经细胞相关的终末分化指标的表达,从而对人神经母细胞瘤细胞的终末分化具有显著的诱导作用。     

维甲酸和EGF对大鼠脑胚胎神经干细胞增殖和分化的影响

目的 观察全反式维甲酸(RA)和表皮生长因子(EGF)对大鼠胚胎神经干细胞增殖和分化的影响。方法 从大鼠胚胎脑中分离神经干细胞,经RA和EGF处理后,用台盼蓝确定细胞数量,BrdU标记分析细胞生长能力,采用免疫细胞化学法鉴定神经干细胞和分化的神经细胞。结果 20ng／ml EGF和1μmol／LRA处理的培养细胞均显示增殖效应,但EGF处理组增殖速度明显高于RA组,悬浮细胞中有大量nestin和BrdU阳性细胞。用EGF和EGE／RA诱导的神经元分化率分别为17％和31％,而RA处理的神经元分化率显升高至89％。由EGF、EGF／RA和RA诱导的星形胶质细胞分化率分别为83％、69％和11％。结论 EGF主要促进神经干细胞增殖并主要诱导星形胶质细胞的生成,RA主要诱导神经干细胞向神经元分化,二无明显协同效应。     

丹参酮ⅡA对人成骨肉瘤MG-63细胞形态结构和终末分化指标的影响

目的:观察中药有效成分丹参酮ⅡA(Tan ⅡA)对人成骨肉瘤MG-63细胞形态与超微结构和相关终末分化指标的影响,以鉴定其对肿瘤细胞终末分化的诱导作用.方法:0.5μg/mL丹参酮ⅡA处理MG-63细胞,光镜、电镜观察和免疫细胞化学检测系统研究MG-63细胞处理前后细胞形态、超微结构变化和成骨细胞相关终末分化蛋白的表达变化.结果:光镜与电镜观察结果显示经Tan ⅡA处理细胞产生了核质比例减小、异染色质减少、常染色质增多、细胞器丰富发达、细胞表面微绒毛减少等显著变化;免疫细胞化学检测显示处理后MG-63细胞I型胶原蛋白、骨粘素和骨钙蛋白的表达呈阳性,并观察到钙化糖原颗粒增多和典型骨结节的形成.结论:丹参酮ⅡA能显著改变MG-63细胞形态与超微结构恶性特征,并促进与成骨细胞相关的终末分化指标的表达变化,从而对人成骨肉瘤细胞的终末分化具有明显的诱导作用.     

维甲酸对SK-N-SH细胞增殖和相关基因表达的影响

目的:研究维甲酸对SK-N-SH细胞的增殖和相关基因表达的影响.方法:通过苔盼蓝排除法绘制细胞生长曲线、流式细胞技术测定细胞周期、HE染色光镜观察细胞形态改变以及SABC免疫细胞化学梁色法观察维甲酸对SK-N-SH相关癌基因、抑癌基因表达的影响.结果:1μmol/LRA处理后,SK-N-SH细胞的增殖活动受到明显的抑制,处理第7天抑制率达36.16%;周期测定显示处理后出现明显的G0/G1期阻滞,由对照组的49.7%增加至62.7%,增加了26.2%;免疫细胞化学染色结果显示,处理后细胞癌基因c-myc、c-fos的表达较对照组明显降低,而抑癌基因p53、p27的表达则有所加强.结论:维甲酸能有效抑制SK-N-SH细胞的增殖活动,其对细胞的增殖抑制作用与RA下调c-myc、c-fos等癌基因以及上调p53、p27等抑癌基因的表达有关.     

视黄酸诱导人神经母细胞瘤SK-N-SH细胞分化过程中核基质蛋白组成的变化

在鉴定视黄酸(retinoic acid, RA)诱导人神经母细胞瘤SK-N-SH细胞分化的基础上,应用免疫细胞化学、选择性抽提和蛋白质组学分析技术,对SK-N-SH细胞诱导分化过程中核基质蛋白组成变化进行了系统研究.实验结果显示,经1 μmol/L RA处理后SK-N-SH细胞呈极性状,伸出较长的轴突样突起,胞体逐渐变小变圆.免疫细胞化学结果显示,处理后神经细胞特异表达的蛋白synaptophysin、NSE、MAP2的表达量都较对照组有明显增强.双向凝胶电泳分析显示,在RA诱导SK-N-SH细胞分化前后存在52个差异表达的核基质蛋白,经质谱分析,鉴定了其中的41个蛋白.蛋白印迹杂交进一步确证了诱导分化差异表达核基质蛋白中nucleophosmin和prohibitin等的表达变化.研究结果表明,1 μmol/L RA对SK-N-SH细胞具有显著的诱导分化作用,在SK-N-SH细胞分化过程中,其核基质蛋白组成发生了明显变化.这些变化对于揭示人神经母细胞瘤细胞癌变与逆转机制和肿瘤细胞增殖与分化调控机理均有十分重要的意义,从而为研究神经系统正常发育过程及神经系统疾病的发病机理提供科学依据.     

应用寡核苷酸芯片筛选维甲酸诱导神经母细胞瘤细胞系SH-SY5Y分化成神经元过程中的差异表达基因

目的:应用寡核苷酸芯片筛选维甲酸(RA)诱导神经母细胞瘤细胞系SH-SY5Y分化成神经元过程中的差异表达基因。方法:从人胎脑及不同类型神经系统肿瘤组织中获取目的基因,查询相应基因mRNA序列,设计并合成探针,制备了含218种基因的神经功能相关的寡核苷酸芯片。应用RA诱导SH-SY5Y8d分化成成熟神经元,提取对照组和实验组每天的总RNA,通过逆转录荧光标记cDNA探针并与芯片杂交,洗片后扫描获取图像,数据分析获得差异表达基因,并通过RT-PCR进行验证。结果:发现13种基因表达上调,没有得到下调基因。RT-PCR验证结果基本与芯片结果一致。结论:SH-SY5Y经RA诱导分化成神经元存在一些差异表达的基因,寡核苷酸芯片技术可为研究SH-SY5Y诱导分化成神经元的分子作用机理提供技术平台。     

脑啡肽对小鼠神经母细胞瘤细胞脂褐素影响的实验研究

本文应用小鼠神经母细胞瘤细胞Ａ２（ＮＢ－Ａ２）无血清培养建立的神经细胞老化实验研究模型,以显微荧光分光光度术测定单个细胞内脂褐素荧光值作为细胞老化指标,观察了脑啡肽（ＬＥ）对ＮＢＡ２细胞内脂褐素荧光值的影响。结果表明ＬＥ可显著降低细胞内的脂褐素荧光值（Ｐ〈０．０１）。提示ＬＥ可延缓ＮＢＡ２细胞的老化进程。     

蛋白磷酸酯酶抑制剂冈田酸对人神经母细胞瘤 SK-N-SH细胞系tau蛋白磷酸化水平的影响

观察蛋白磷酸酯酶-1和蛋白磷酸酯酶-2A的抑制剂冈田酸(okadaicacid,OA)对人神经母细胞瘤系SK-N-SH细胞tau蛋白磷酸化水平的变化,确定tau蛋白过度磷酸化细胞模型的合适剂量和时间。用不同剂量OA与SK-N-SH细胞共温育不同时间,用显微镜观察细胞形态变化,用Western印迹法检测磷酸化tau蛋白和非磷酸化tau蛋白在Ser202位点和Ser404位点磷酸化水平的变化。10～160nmol/LOA与SK-N-SH神经细胞温育3～24h,可引起细胞形态损伤呈剂量依赖性和时间依赖性的变化,起效剂量和时间为10nmol/L和3h。10nmol/LOA与SK-N-SH细胞温育6～24h,磷酸化tau蛋白Ser199/Ser202位点和Ser404位点的表达明显增高,非磷酸化tau蛋白Ser202位点和Ser404位点的表达明显降低,总tau蛋白含量无明显变化。OA可以作为很好的研究tau蛋白过度磷酸化的工具药,10nmol/LOA与SK-N-SH神经细胞共温育6h可以作为制备细胞模型的适宜条件。     

维甲酸激活基因cDNA RA538诱发人食管癌细胞终末分化与凋亡

将含有RA538的真核表达载体pCDV1与含neo基因的表达载体pDOR-neo经Lipofectin法共转染到人食管癌细胞系EC8712,EC109细胞,结果表明:RA538的表达对两细胞系均有很强的生长抑制作用,引起细胞形态的明显改变,诱发细胞终末分化与死亡。RT-PCR分析发现,RA538的表达激活了谷氨酰胺转移酶(transglutaminase,TGase)基因的表达,引起c-myc基因表达下降,被膜素(involu-crin)基因表达增加.而对TGF-β基因的表达没有明显的影响.应用凋亡细胞原位检测法证实,RA538表达诱发的细胞死亡是通过细胞凋亡而实现的.以上结果与直接用维甲酸处理人食管癌细胞后所得结果相似 因此认为:RA538是维甲酸诱导人食管癌细胞发生终末分化和凋亡过程中一系列被激活基因中的1个关键基因.     

神经肽对神经母细胞瘤细胞分裂和代谢的影响

神经-内分泌-免疫系统作为机体的整合系统,在衰老变化的发生和发展过程中起着重要的作用。一些资料表明,伴随神经系统的老化,脑和脑脊液中一些神经肽也显著变化。本实验采用小鼠神经母细胞瘤细胞无血清培养建立神经细胞老化实验研究模型,以流式细胞光度术研究神经肽对无血消培养的神经母细胞瘤细胞的细胞周期和细胞总蛋白的影响。以了解神经肽对神经细胞老化过程中的DNA和细胞总蛋白的影响。1 材料与方法     

Retinoic Acid Rapidly Decreases Phosphatidylinositol Turnover During Neuroblastoma Cell Differentiation

Phosphatidylinositol (PI) turnover has recently been implicated in the regulation of cell proliferation and transformation. We have investigated its role in differentiation using LAN-1 cells, a human neuroblastoma cell line that can be induced to differentiate along the neuronal pathway by retinoic acid (RA). We have found that treatment of LAN-1 cells with RA is followed by a rapid decrease of inositol phospholipid metabolism, using myo-[1,2-3H]inositol or [1(3)-3H]glycerol. No changes were observed in both [3H]inositol and [3H]glycerol uptake within 24 h of RA treatment. Decreased incorporation of the metabolic precursor into PI 4-monophosphate and PI 4,5-bisphosphate occurred within 1 h of RA treatment. No changes were seen in the specific radioactivity of the precursor pools up to 1 h of treatment with RA. Analysis of labeled PI metabolites from prelabeled cells indicated a rapid decrease of inositol 1,4,5-trisphosphate and 1,2-diacylglycerol content within 1 min of induction of LAN-1 cell differentiation. These findings constitute the earliest reported events in neuroblastoma cell differentiation.     

Localization of Prohibitin in the Nuclear Matrix and Alteration of Its Expression During Differentiation of Human Neuroblastoma SK-N-SH Cells Induced by Retinoic Acid

The nuclear matrix-intermediate filament system of human neuroblastoma SK-N-SH cells before and after retinoic acid (RA) treatment was selectively extracted and the distribution of prohibitin (PHB) in the nuclear matrix, as well as its colocalization with related genes, was observed. Results of two-dimensional gel electrophoresis (2-DE), mass spectrometry (MS) identification, and protein immunoblotting all confirm that PHB was present in the components of SK-N-SH nuclear matrix proteins and was down-regulated after RA treatment. Immunofluorescence microscopy observations show that PHB was localized in the nuclear matrix and its distribution was altered due to RA treatment. Laser confocal microscopy results reveal that PHB colocalized with the expression products of c-myc, c-fos, p53, and Rb, but the colocalization region was altered after RA treatment. Our results prove that PHB is a nuclear matrix protein and is localized in nuclear matrix fibers. The distribution of PHB in SK-N-SH cells and its colocalization with related proto-oncogenes and tumor suppressor genes suggest that PHB plays pivotal roles in the differentiation of SK-N-SH cells and deserves further study.     

Effects of Dibutyryl Cyclic AMP and Retinoic Acid on the Differentiation of Dopamine Neurons: Prevention of Cell Death by Dibutyryl Cyclic AMP

Abstract: Immature neurons, including fetal and tumoral cells, are used for investigating neuronal differentiation in vitro. The human neuroblastoma cell line NB69 could be induced to differentiate to dopamine or acetylcholine neurons by different compounds, including neurotrophins and activators of the protein kinases. In these NB69 cells dibutyryl cyclic AMP (dbcAMP) at 2 m M reduced the division rate and increased the levels of catecholamines, tyrosine hydroxylase (TH) activity, and monoamine oxidase activity. The dbcAMP also increased cell size, dendritic arborization, density of the sites for high-affinity dopamine uptake, and activity of choline acetyltransferase. In fetal rat midbrain neurons treatment with dbcAMP increased the levels of dopamine and the number of TH-immunoreactive neurons in the culture. When embryonic day 14 fetal midbrain neurons, previously exposed to 1 µ M retinoic acid (a compound that severely reduces the number of fetal midbrain dopamine neurons), were treated with dbcAMP, the levels of dopamine and the number of TH-immunoreactive cells returned to normal levels. This suggests that dbcAMP induces the differentiation to dopamine neurons of quiescent progenitor or facilitates expression of the dopamine phenotype in immature neurons. Therefore, dbcAMP not only differentiates uncommitted immature dopamine neurons, but also reverses the antidopaminergic effects of retinoic acid. These properties of dbcAMP could be of therapeutic value in Parkinson's disease.     

全反式维甲酸诱导胃腺癌细胞周期阻滞的作用机制

目的:研究全反式维甲酸(all trans retinoic acid,ATRA)对人胃腺癌细胞(SGC-7901)细胞周期阻滞的诱导作用并探讨其机制.方法:采用四甲基偶氮唑盐(MTT)方法检测ATRA对SGC-7901增殖的抑制;流式细胞术检测细胞周期,Western blot方法检测不同浓度ATRA处理后的SGC-7901细胞中Akt、P-Akt(Ser473)、P-Akt(Thr308)、p-GSK-3β(Ser9)和cyclin D1的表达情况.结果:10.9～10.5mol/L的ATRA作用SGC-7901细胞48 h,能显著抑制细胞增殖,其抑制率分别为10.2%±0.5%、15.3%±0.5%、17.0%±0.7%、28.4%±1.0%和36.9%±0.7%;G1期细胞比率随着ATRA浓度的增加而增加,呈明显的G1期阻滞;Western blot检测显示ATRA对细胞中Akt蛋白的表达没有明显影响,两种p-Akt蛋白的表达显著下调,ATRA显著降低细胞中cyclin D1和p-GSK-3β的表达.结论:ATRA可能通过抑制磷酸化Akt蛋白表达而减少p-GSK-3β的表达,从而减少cyclin D1的表达量,进而诱导SGC-7901细胞发生G1期阻滞.